Development of an ultra-sensitive assay for the determination of an aminoalkyl glucosaminide 4-phosphate, GSK1795091, in plasma to support a first time in human study-Reference-Cited by-同舟云学术

Development of an ultra-sensitive assay for the determination of an aminoalkyl glucosaminide 4-phosphate, GSK1795091, in plasma to support a first time in human study

Published:2018 Issue:25 Volume:10 Page:3074-3080
ISSN:1759-9660
Container-title:Analytical Methods
language:en
Short-container-title:Anal. Methods

Author:

Licea-Perez Hermes¹²³⁴⁵^ORCID,Junnotula Venkatraman¹²³⁴⁵,Bowen Chester L.¹²³⁴⁵,Fang Kasie¹²³⁴⁵,Qian Yanwen¹²³⁴⁵,Matheny Christopher¹²³⁴⁵

Affiliation:

1. Bioanalysis, Immunogenicity, and Biomarkers

2. PTS – In Vivo/In Vitro Translation and Immuno-Oncology & Combinations DPU (CM)

3. GlaxoSmithKline Pharmaceuticals

4. King of Prussia

5. USA

Abstract

A chemical derivatization approach for the determination of an aminoalkyl glucosaminide 4-phosphate, GSK1795091 (or CRX-601).

Publisher

Royal Society of Chemistry (RSC)

Subject

General Engineering,General Chemical Engineering,Analytical Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2018/AY/C8AY00571K

Reference10 articles.

1. Future perspectives in cancer immunotherapy

2. A phase 2 study of patupilone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel: Canadian Urologic Oncology Group study P07a

3. Development of immuno-oncology drugs — from CTLA4 to PD1 to the next generations

4. Innate Immune Pattern Recognition: A Cell Biological Perspective

5. TLR4 agonists as immunomodulatory agents

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diamino Allose Phosphates: Novel, Potent, and Highly Stable Toll-like Receptor 4 Agonists;Journal of Medicinal Chemistry;2023-10-17

2. Manufacturing‐dependent change in biological activity of the TLR4 agonist GSK1795091 and implications for lipid A analog development;Clinical and Translational Science;2022-09-12

3. Safety, Pharmacokinetics, and Pharmacodynamics of the TLR4 Agonist GSK1795091 in Healthy Individuals: Results from a Randomized, Double-blind, Placebo-controlled, Ascending Dose Study;Clinical Therapeutics;2020-08

4. Strategies for effective development of ultra-sensitive LC–MS/MS assays: application to a novel STING agonist;Bioanalysis;2020-04

5. TLR4-Based Immunotherapeutics in Cancer: A Review of the Achievements and Shortcomings;Molecular Pharmaceutics;2018-09-18